INVASIVE DUCTAL BREAST CARCINOMA
Clinical trials for INVASIVE DUCTAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE DUCTAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE DUCTAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cold sore virus engineered to attack breast cancer shows promise in early trial
Disease control CompletedThis study tested whether injecting a modified herpes virus (talimogene laherparepvec) directly into breast tumors, alongside standard chemotherapy before surgery, could destroy more cancer cells in people with triple negative breast cancer. The virus is designed to infect and br…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 04, 2026 16:23 UTC
-
New ovarian stimulation method aims to keep estrogen low during fertility preservation
Symptom relief CompletedThis study tested a new ovarian stimulation protocol using degarelix, a drug typically used for prostate cancer, to help breast cancer patients preserve their fertility before chemotherapy. The goal was to stimulate the ovaries to produce eggs while keeping estrogen levels low, w…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated May 26, 2026 03:23 UTC
-
Shrinking tumors before surgery: a gentler approach to breast cancer?
Symptom relief CompletedThis study tested whether giving a high dose of focused radiation to the tumor before surgery is a safe and effective approach for older patients with early-stage, hormone-sensitive breast cancer. The goal was to shrink the tumor and reduce the amount of healthy tissue removed du…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC